MMP2 and pulmonary emphysema: Cyclooxygenase (COX)-2 and its product prostaglandin E2 are elevated in sputum of COPD patients, and they contribute to the severity of emphysema (airflow limitation) mediated by matrix metalloproteinase-2 during progression of COPD [39].